Top

Published in:

01-06-2017 | Original Article

The impact of peer victimization and psychological symptoms on quality of life in children and adolescents with systemic lupus erythematosus

Authors: Selcuk Uzuner, Sezgin Sahin, Gizem Durcan, Amra Adrovic, Kenan Barut, Ali Guven Kilicoglu, Ayhan Bilgic, Kayhan Bahali, Ozgur Kasapcopur

Published in: Clinical Rheumatology | Issue 6/2017

Abstract

There is no documentation about the association between peer victimization, psychological status, and quality of life (QOL) in children and adolescents with systemic lupus erythematosus (SLE). The aim of this study was to evaluate the association between peer victimization, psychological symptoms, and QOL in a cohort of children and adolescents with SLE. Forty-one patients (aged 9–18 years) participated in this study. The control group (n = 49) was composed of healthy children and adolescents from local community. Questionnaires were used to evaluate the peer victimization, psychological status, and QOL of children and adolescents with and without SLE. No significant difference was found between the study and control groups for peer victimization, depression, state and trait anxiety, and QOL scores. The peer victimization, depression, anxiety, and self-esteem scores were negatively correlated with psychosocial and total subscale scores of QOL in the study group. According to regression analyses, trait anxiety had a negative predictive effect on the physical health domain scores of QOL, whereas trait anxiety and peer victimization had a negative effect on the psychosocial domain and total scores of QOL in the SLE patients. This study suggests that trait anxiety and peer victimization are risk factors for poor QOL in adolescents with SLE.

Malattia C, Martini A (2013) Paediatric-onset systemic lupus erythematosus. Best Pract Res Clin Rheumatol 27:351–362CrossRefPubMed

Meszaros ZS, Perl A, Faraone SV (2012) Psychiatric symptoms in systemic lupus erythematosus: a systematic review. J Clin Psychiatry 73:993–1001CrossRefPubMed

Jones JT, Cunningham N, Kashikar-Zuck S, Brunner HI (2016) Pain, fatigue, and psychological impact on health-related quality of life in childhood-onset lupus. Arthritis Care Res (Hoboken) 68:73–80CrossRef

Brunner HI, Higgins GC, Wiers K, Lapidus SK, Olson JC, Onel K, Punaro M, Ying J, Klein-Gitelman MS, Seid M (2009) Health-related quality of life and its relationship to patient disease course in childhood-onset systemic lupus erythematosus. J Rheumatol 36:1536–1545CrossRefPubMed

Ruperto N, Buratti S, Duarte-Salazar C, Pistorio A, Reiff A, Bernstein B, Maldonado-Velázquez MR, Beristain-Manterola R, Maeno N, Takei S, Falcini F, Lepore L, Spencer CH, Pratsidou-Gertsi P, Martini A, Ravelli A (2004) Health-related quality of life in juvenile onset systemic lupus erythematosus and its relationship to disease activity and damage. Arthritis Rheum 51:458–464CrossRefPubMed

Ji L, Lili S, Jing W, Yanyan H, Min W, Juan X, Hongmei S (2012) Appearance concern and depression in adolescent girls with systemic lupus erythematous. Clin Rheumatol 31:1671–1675CrossRefPubMed

Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E, Silverman ED (2008) Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr 152:550–556CrossRefPubMed

Bader-Meunier B, Armengaud JB, Haddad E, Salomon R, Deschênes G, Koné-Paut I, Leblanc T, Loirat C, Niaudet P, Piette JC, Prieur AM, Quartier P, Bouissou F, Foulard M, Leverger G, Lemelle I, Pilet P, Rodière M, Sirvent N, Cochat P (2005) Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr 146:648–653CrossRefPubMed

Magin P (2013) Appearance-related bullying and skin disorders. Clin Dermatol 31:66–71CrossRefPubMed

10.

Zhu J, Yu C, Zhang W, Bao Z, Jiang Y, Chen Y, Zhen S (2016) Peer victimization, deviant peer affiliation and impulsivity: predicting adolescent problem behaviors. Child Abuse Negl 58:39–50CrossRefPubMed

11.

Begle AM, Hanson RF, Danielson CK, McCart MR, Ruggiero KJ, Amstadter AB, Resnick HS, Saunders BE, Kilpatrick DG (2011) Longitudinal pathways of victimization, substance use, and delinquency: findings from the National Survey of Adolescents. Addict Behav 36:682–689CrossRefPubMedPubMedCentral

12.

Ostrov JM (2010) Prospective associations between peer victimization and aggression. Child Dev 81:1670–1677CrossRefPubMed

13.

Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725.

14.

Brunner HI, Feldman BM, Bombardier C, Silverman ED (1999) Sensitivity of the systemic lupus erythematosus disease activity index, British isles lupus assessment group index, and systemic lupus activity measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum 42:1354–1360CrossRefPubMed

15.

Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288–291PubMed

16.

Maynard H, Joseph S (2000) Development of the multidimensional victimization scale. Aggress Behav 26:169–178CrossRef

17.

Gultekin Z, Sayil M (2005) A study of reliability and validity of the peer victimization scale. Turkish Psychological Articles 8:47–61 [In Turkish]

18.

Öy B (1991) Children’s depression inventory: validity and reliability study. Turk Psikiyatri Derg 2:132–136 [In Turkish]

19.

Özusta S (1995) Turkish standardization, reliability and validity of State Trait Anxiety Inventory for children. Turk J Psychol 10:32–44 [In Turkish]

20.

Varni JW, Seid M, Rode CA (1999) The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 37:126–139CrossRefPubMed

21.

Cakın Memik N, Agaoglu B, Coskun A, Uneri OS, Karakaya I (2007) The validity and reliability of the Turkish pediatric quality of life inventory for children 13–18 years old. Turk Psikiyatri Derg 18:353–363 [In Turkish] PubMed

22.

Cuhadaroglu F (1986) Self-esteem in adolescents. Hacettepe University, Turkey, Doctoral dissertation

23.

Wolke D, Woods S, Bloomfield L, Karstadt L (2001) Bullying involvement in primary school and common health problems. Arch Dis Child 85(3):197–201CrossRefPubMedPubMedCentral

24.

Rueger SY, Jenkins LN (2014) Effects of peer victimization on psychological and academic adjustment in early adolescence. Sch Psychol Q 29(1):77–88CrossRefPubMed

25.

Wu L, Zhang D, Su Z, Hu T (2015) Peer victimization among children and adolescents: a meta-analytic review of links to emotional maladjustment. Clin Pediatr (Phila) 54(10):941–955CrossRef

26.

van Weelden M, Queiroz LB, Lourenço DM, Kozu K, Lourenço B, Silva CA (2016) Alcohol, smoking and illicit drug use in pediatric systemic lupus erythematosus patients. Rev Bras Reumatol (Rio J) 56:228–234CrossRef

27.

Sentenac M, Gavin A, Gabhainn SN, Molcho M, Due P, Ravens-Sieberer U, Matos MG, Malkowska-Szkutnik A, Gobina I, Vollebergh W, Arnaud C, Godeau E (2013) Peer victimization and subjective health among students reporting disability or chronic illness in 11 Western countries. Eur J Pub Health 23:421–426CrossRef

28.

Janicke DM, Marciel KK, Ingerski LM, Novoa W, Lowry KW, Sallinen BJ, Silverstein JH (2007) Impact of psychosocial factors on quality of life in overweight youth. Obesity (Silver Spring) 15:1799–1807CrossRef

29.

Storch EA, Lewin A, Silverstein JH, Heidgerken AD, Strawser MS, Baumeister A, Geffken GR (2004) Peer victimization and psychosocial adjustment in children with type 1 diabetes. Clin Pediatr 43:467–471CrossRef

30.

Jarpa E, Babul M, Calderón J, González M, Martínez ME, Bravo-Zehnder M, Henríquez C, Jacobelli S, González A, Massardo L (2011) Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity. Lupus 20:58–66CrossRefPubMed

31.

Demirkaya E, Bilginer Y, Aktay-Ayaz N, Yalnizoğlu D, Karli-Oğuz K, Işikhan V, Türker T, Topaloğlu R, Beşbaş N, Bakkaloğlu A, Ozen S (2008) Neuropsychiatric involvement in juvenile systemic lupus erythematosus. Turk J Pediatr 50:126–131PubMed

32.

Knight A, Weiss P, Morales K, Gerdes M, Gutstein A, Vickery M, Keren R (2014) Depression and anxiety and their association with healthcare utilization in pediatric lupus and mixed connective tissue disease patients: a cross-sectional study. Pediatr Rheumatol Online J 12:42CrossRefPubMedPubMedCentral

33.

Kohut SA, Williams T, Jayanthikumar J, Landolt-Marticorena C, Lefebvre A, Silverman E, Levy DM (2013) Depressive symptoms are prevalent in childhood-onset systemic lupus erythematosus (cSLE). Lupus 22:712–720CrossRefPubMed

34.

Louthrenoo O, Krairojananan J, Chartapisak W, Opastirakul S (2012) Psychosocial functioning of children with systemic lupus erythematosus. J Paediatr Child Health 48:1091–1094CrossRefPubMed

35.

Tamayo T, Fischer-Betz R, Beer S, Winkler-Rohlfing B, Schneider M (2010) Factors influencing the health related quality of life in patients with systemic lupus erythematosus: long-term results (2001-2005) of patients in the German Lupus Erythematosus Self-Help Organization (LULA Study). Lupus 19:1606–1613CrossRefPubMed

36.

Khanna S, Pal H, Pandey RM, Handa R (2004) The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology (Oxford) 43:1536–1540CrossRef

37.

Houghton KM, Tucker LB, Potts JE, McKenzie DC (2008) Fitness, fatigue, disease activity, and quality of life in pediatric lupus. Arthritis Rheum 59:537–545CrossRefPubMed

38.

Bahali AG, Bahali K, Biyik Ozkaya D, Bilgic A, Su O, Onsun N (2016) The associations between peer victimization, psychological symptoms and quality of life in adolescents with acne vulgaris. J Eur Acad Dermatol Venereol 30(12):e184–e186CrossRefPubMed

39.

Papadimitraki ED, Isenberg DA (2009) Childhood- and adult-onset lupus: an update of similarities and differences. Expert Rev Clin Immunol 5(4):391–403CrossRefPubMed

40.

Drozdowicz LB, Bostwick JM (2014) Psychiatric adverse effects of pediatric corticosteroid use. Mayo Clin Proc 89(6):817–834CrossRefPubMed

Title: The impact of peer victimization and psychological symptoms on quality of life in children and adolescents with systemic lupus erythematosus
Authors: Selcuk Uzuner
Sezgin Sahin
Gizem Durcan
Amra Adrovic
Kenan Barut
Ali Guven Kilicoglu
Ayhan Bilgic
Kayhan Bahali
Ozgur Kasapcopur
Publication date: 01-06-2017
Publisher: Springer London
Published in: Clinical Rheumatology / Issue 6/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-017-3650-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2017

Gastrointestinal and liver lesions in primary childhood Sjögren syndrome

Expression of CCR6 on B cells in systemic lupus erythematosus patients

Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome

Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt

A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?

Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials